Halozyme Therapeutics
Greg Elias has over 20 years of experience in sales and management roles in the pharmaceutical and healthcare industry. Greg has held various leadership positions, including Vice President of Sales at Halozyme Therapeutics, Division of CLDA, and Regional Sales Director at InterMune. Greg has a strong background in sales operations, managed markets, and specialty pharmacy. Greg began their career as an Executive Sales Representative at GSK, where they worked for almost a decade.
Greg Elias obtained their Bachelor of Science (B.S.) degree in Business Administration with a focus on Marketing from the University of South Carolina. Greg pursued this degree from 1987 to 1992.
This person is not in any offices
Halozyme Therapeutics
7 followers
Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies.